Makale, 2026
Development and validation of a GC-MS method for the simultaneous determination of bisphenols, phthalate monoesters, and triclosan in human meconium for comprehensive prenatal exposure assessment
Journal of Pharmaceutical and Biomedical Analysis, 279, 117556
- Atıf
- 0 (Crossref)
Kaynak gösterimi
Tok, K. C., Gumustas, M., Masoud, K. M., Arsan, S., Bolkan, A. G., & Suzen, H. S. (2026). Development and validation of a GC-MS method for the simultaneous determination of bisphenols, phthalate monoesters, and triclosan in human meconium for comprehensive prenatal exposure assessment. Journal of Pharmaceutical and Biomedical Analysis, 279, 117556. https://doi.org/10.1016/j.jpba.2026.117556
Tok KC, Gumustas M, Masoud KM, Arsan S, Bolkan AG, Suzen HS. Development and validation of a GC-MS method for the simultaneous determination of bisphenols, phthalate monoesters, and triclosan in human meconium for comprehensive prenatal exposure assessment. Journal of Pharmaceutical and Biomedical Analysis. 2026;279:117556. doi:10.1016/j.jpba.2026.117556
Tok, Kenan Can, Mehmet Gumustas, Khaled Mohamed Masoud, Saadet Arsan, Aslihan Gurbuz Bolkan, and H. Sinan Suzen. 2026. “Development and validation of a GC-MS method for the simultaneous determination of bisphenols, phthalate monoesters, and triclosan in human meconium for comprehensive prenatal exposure assessment.” Journal of Pharmaceutical and Biomedical Analysis 279: 117556. https://doi.org/10.1016/j.jpba.2026.117556.
Tok, Kenan Can, et al. “Development and validation of a GC-MS method for the simultaneous determination of bisphenols, phthalate monoesters, and triclosan in human meconium for comprehensive prenatal exposure assessment.” Journal of Pharmaceutical and Biomedical Analysis, vol. 279, 2026, p. 117556. https://doi.org/10.1016/j.jpba.2026.117556.
Tok, K.C., Gumustas, M., Masoud, K.M., Arsan, S., Bolkan, A.G. and Suzen, H.S. (2026) ‘Development and validation of a GC-MS method for the simultaneous determination of bisphenols, phthalate monoesters, and triclosan in human meconium for comprehensive prenatal exposure assessment’, Journal of Pharmaceutical and Biomedical Analysis, 279, p. 117556. doi:10.1016/j.jpba.2026.117556.